Hypoaldosteronism diagnostic criteria

Hypoaldosteronism Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hypoaldosteronism from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hypoaldosteronism diagnostic criteria On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hypoaldosteronism diagnostic criteria All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hypoaldosteronism diagnostic criteria
CDC on Hypoaldosteronism diagnostic criteria
Hypoaldosteronism diagnostic criteria in the news
Blogs on Hypoaldosteronism diagnostic criteria
Directions to Hospitals Treating Hypoaldosteronism
Risk calculators and risk factors for Hypoaldosteronism diagnostic criteria

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

There are no established criteria for the diagnosis of hypoaldosteronism.

Diagnostic Criteria

• There is no established criteria for the diagnosis of hypoaldosteronism. However, patients with suspected hypoaldosteronism should be tested for underlying conditions which can lead to decreased aldosterone level or aldosterone resistance such as diabetes, chronic kidney disease, serum mineralocorticoid, corticosteroid and androgen level. Patients with family history of hypoaldosteronism should also be checked for CYP11B2 and mutations in aldosterone receptor genes. Complete history should also be obtained regarding drug use which can affect aldosterone synthesis such as NSAID, ACEi, B blockers, heparin, calcineurin inhibitors.